John Tannahill Henderson
Independent ChairmanDr. John Tannahill Henderson, BSc. M.B, Ch.B, MRCP, M.D., Ph.D., was an Independent Director of Myriad Genetics, Inc. since May 1, 2004 until December 4, 2020. He serves as an Independent Chairman at Cytokinetics, Incorporated since April 8, 2022. Since December 2000, Dr. Henderson has served as a consultant to the pharmaceutical industry as president of Futurepharm Limited Liability Company. Dr. Henderson consulted for NeuroVia, Incorporated as Chief Development Officer and was an executive officer of this privately held company until October 2018. He has been a Consultant to the Pharmaceutical industry through Futurepharm LLC since December 2000. Dr. Henderson has extensive experience in a broad range of therapeutic areas, including cardiovascular, the central nervous system, anti-infective, anti-inflammatory agents, urology and gastro-enterology. Prior to FuturePharm LLC, from December 1974 to December 2000, he served at Pfizer for over 30 years and served as a Vice President in its Pharmaceuticals Group. Dr. Henderson served in Vice Presidential level positions with Pfizer in Research and Development in Europe and later in Japan. Dr. Henderson served as Vice President of Medical for Europe, U.S. and International Pharmaceuticals group at Pfizer. He was significantly involved in determining and implementing the development strategy for current pharmaceutical products discovered by Pfizer, including Cordura, Diflucan, Norvasc, Zithromax and Zoloft. Dr. Henderson has been the Chairman of Asmacure Ltée since April 2009. Dr. Henderson served as an Independent Chairman of Myriad Genetics Inc. since April 2005 until March 2020. Dr. Henderson has been a Director at Cytokinetics, Incorporated since February 2009. Dr. Henderson serves as a Member of Scientific Advisory Board at ITI Life Sciences. Dr. Henderson served as a Director at Myrexis, Inc. from February 19, 2009 to January 23, 2013. Dr. Henderson served as a Director of Misonix, Inc., since May 2004. Dr. Henderson served as a Director of Inveresk Research Group Inc. since March 2002 and as its Lead Director since May 2004. Dr. Henderson is a Fellow of the Royal College of Physicians (Ed.) and the Faculty of Pharmaceutical Medicine. Dr. Henderson holds BS degree in 1965 and Medical Degree in 1968 from the University of Edinburgh.
Positions
- Company NameCytokinetics, IncorporatedStock CodeCYTKPositionIndependent ChairmanColleagues
- RIRobert I. BlumCEO, President & Director
- SHSung H. LeeEVP & CFO
- JJJeffrey J. HessekielExecutive VP, Chief Legal & Administrative Officer
- FIFady Ibraham MalikExecutive Vice President of Research & Development
- AMAndrew M. CallosExecutive VP & Chief Commercial Officer
- JHJames H. SabryCo-Founder & Chairman of Scientific Advisory Board
- JAJames A. SpudichCo-Founder & Member of Scientific Advisory Board
- BLB. Lynne ParshallIndependent Director
